Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 研究・開発
  • 研究ソリューション
  • バイオロジクス
    • Bioprocessing
    • Cellular Internalization Kits and Reagents
    • Agrigenomics Workflows
    • アッセイ開発ワークフロー
    • Biobanking Workflows
    • バイオロジクス
    • Biomarker Discovery
    • 細胞・遺伝子治療
    • 疾患研究
    • 医薬品開発
    • 機能ゲノミクススクリーニングソリューション
    • GMP Workflows
    • Immunoassays Solutions
    • Microphysiological Systems
    • プレシジョン・メディシン・リサーチ
    • 低分子創薬
    • ターゲットクラス
  • Biologics Characterization
    • Biologics Characterization
    • Biomolecular Discovery
    • Host Cell Contamination Detection Solutions
    • Immune function
    • Manufacturing and QA/QC of Biologics
    • Next-Generation Biologics
    • Safety & Efficacy
  • Biologics Potency
    • Biologics Identity
    • Biologics Potency
    • Biologics Purity & Impurity Profile

Biologics Potency

Delivering consistent biological activity and potency

A biological drug’s stability during development and storage, and its impact on dosage and activity are critical quality attributes that need evaluation.

With relative potency of a biological drug product being determined by comparing the biological response with a control via determination of mode of action, we offer a range of bioassays to aid this assessment.

Our bioassays, including cell-based assays, help determine the potency and evaluate the reproducibility and stability of your drug product. While our assay platforms, automation and bioanalytical solutions can offer high throughput workflows for you to establish reproducible methods when determining potency during your late-stage drug discovery.


For research use only. Not for use in diagnostic procedures.

Potency_872X872

Explore our solutions

Fontus deck closeup-thumb.jpg

自動液体分注機

Revvityは、40年以上にわたりラボの研究加速を支援する液体分注ソリューションを提供してきました。
Learn more
microplate readers

マイクロプレートリーダー

Revvityのプレートリーダー製品群は、今日のラボの多様なアッセイ要件に対応する最新の検出技術を備えています。
Learn more
Immunoassays-New-512x288

Discovery and bioanalytical assays

Our drug discovery and bioanalytical assays cover a range of assay technologies including our no-wash Alpha and LANCE Ultra TR-FRET for simple straightforward homogenous workflows, and our TRF technology offers advantages over traditional ELISAs while maintaining the wash steps.

Learn more
全てを表示 View less

Featured resources

Flyer

Potency detection assays and solutions

Learn more
line

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.